Stock XBIO XENETIC BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Xenetic Biosciences, Inc.

Equities

XBIO

US9840156023

Market Closed - Nasdaq
Other stock markets
 21:30:00 15/05/2024 BST 		5-day change 1st Jan Change
3.956 USD +4.09% Intraday chart for Xenetic Biosciences, Inc. +0.78% +14.65%
05-09 Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-21 Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Xenetic Biosciences, Inc.

63698a73c7873e1b39d85.9O48miivVQAPpt-GSpOpOnWz5WtJkaV3AZ0FdLWxwZc.w5l52F7ZFGpukZHceqfQQzrZsyEE0-0BYOUzK8zW9tuxo3-oY5wceGH2rA~277717456481b47f6a875800cb30963d

Upcoming events on Xenetic Biosciences, Inc.

08/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)
06/05/2026 Q1 2026 Earnings Release (Projected)

Past events on Xenetic Biosciences, Inc.

10/05/2024 13:30 Q1 2024 Earnings Release
06/12/2023 15:00 Annual General Meeting
10/11/2023 13:35 Q3 2023 Earnings Release
24/10/2023 18:00 Virtual Investor Ask the CEO Conference
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
11/08/2023 13:05 Q2 2023 Earnings Release
12/07/2023 15:00 Virtual Investor Summer Spotlight Conference
29/03/2023 16:00 Virtual Investor NETs in Cancer Spotlight Conference
23/03/2023 11:35 Q4 2022 Earnings Release
17/01/2023 15:00 Virtual Investor Conference
10/11/2022 12:05 Q3 2022 Earnings Release
12/09/2022 12:00 H.C. Wainwright Global Investment Conference
11/08/2022 Interim 2022 Earnings Release
09/06/2022 16:00 Investor Innovation in Oncology Event
25/05/2022 21:00 H.C. Wainwright Global Life Sciences Investment Conference
12/05/2022 21:05 Q1 2022 Earnings Release
27/04/2022 13:30 DNase Based Oncology Platform Licensing Update Call
23/03/2022 12:30 FY 2021 Earnings Release
25/01/2022 15:00 JTC Team Virtual Investor Top Picks Conference
07/12/2021 15:00 Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP		Released
Forecast
Spread 		0,01
0,00
- 		0,31
0,31
1.81%		0,88


1,40
1,20
16.2%		2,00
2,12
-5.3%
1,76

EBITDA
Million GBP		Released
Forecast
Spread 		0,00
0,00
- 		-10,0
-10,4
3.95%		-4,34


-5,49
-5,83
5.82%		-3,56
-3,83
6.86%
-4,80

EBIT
Million GBP		Released
Forecast
Spread 		-10,6
-10,0
-6.05%		-10,0
-10,6
5.59%		-4,34


-5,49
-5,83
5.82%		-3,56
-3,83
6.86%
-4,80

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		-10,5
-9,97
-5.52%		-9,95
-10,6
5.76%		-4,26


-5,36
-5,58
3.91%		-3,26
-3,50
6.78%
-4,56

Net income
Million GBP		Released
Forecast
Spread 		-14,9
-9,97
-49.17%		-7,84
-8,34
5.89%		-4,26


-5,36
-5,58
3.91%		-3,26
-3,50
6.78%
-4,56

EPS
USD		Released
Forecast
Spread 		-63,3
-55,6
-13.85%		-17,0
-16,0
-6.25%		-5,50


-4,60
-4,50
-2.22%		-2,71
-2,82
3.9%
-0,96

Announcement Date26/03/2016/03/2122/03/2222/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million GBP		Released
Forecast
Spread 		0,32
0,27
16.94%		0,34
0,28
22.74%		0,36
0,29
26.48%		0,40
0,15
158.53%		0,48
0,34
44.53%		0,51
0,35
45.28%		0,50
0,37
35.22%		0,53
0,55
-4.26%		0,41
0,51
-20.43%
0,43


0,46


0,48

EBITDA
Million GBP		Released
Forecast
Spread 		-1,32
-1,28
-3.55%		-2,20
-1,47
-49.58%		-0,74
-2,29
67.6%		-1,28
-1,46
12.33%		-0,73
-1,55
52.91%		-0,94
-1,44
34.55%		-0,93
-1,52
38.5%		-0,99
-1,22
18.83%		-1,01
-1,11
8.77%
-1,12


-1,28


-1,44

EBIT
Million GBP		Released
Forecast
Spread 		-1,32
-1,28
-3.55%		-2,20
-1,47
-49.58%		-0,74
-2,29
67.6%		-1,28
-1,46
12.33%		-0,73
-1,55
52.91%		-0,94
-1,44
34.55%		-0,93
-1,52
38.5%		-0,99
-1,22
18.83%		-1,01
-1,11
8.77%
-1,12


-1,28


-1,44

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		-1,30
-1,20
-8.68%		-2,19
-1,39
-57.53%		-0,70
-2,21
68.13%		-1,21
-1,20
-0.93%		-0,68
-1,47
53.5%		-0,83
-1,36
39.21%		-0,86
-1,52
43.38%		-0,92
-1,14
18.89%		-0,96
-1,03
7.46%
-1,04


-1,20


-1,36

Net income
Million GBP		Released
Forecast
Spread 		-1,30
-1,20
-8.68%		-2,19
-1,39
-57.53%		-0,70
-2,23
68.36%		-1,21
-1,20
-0.93%		-0,68
-1,47
53.5%		-0,83
-1,36
39.34%		-0,86
-1,52
43.53%		-0,92
-1,14
18.89%		-0,96
-1,03
7.46%
-1,04


-1,20


-1,36

EPS
USD		Released
Forecast
Spread 		-1,20
-1,10
-9.09%		-1,90
-1,20
-58.33%		-0,60
-1,80
66.67%		-1,00
-0,90
-11.11%		-0,60
-1,10
45.45%		-0,69
-1,13
38.94%		-0,69
-1,12
38.39%		-0,77
-0,87
11.49%		-0,78
-0,79
1.27%
-0,83


-0,15


-0,16

Announcement Date12/05/2211/08/2209/11/2222/03/2311/05/2310/08/2309/11/2321/03/2409/05/24---

Upcoming sector events for Xenetic Biosciences, Inc.

17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Xenetic Biosciences, Inc.

Today 14:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
Today BIOCON LIMITED: Q4 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 CELCUITY INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 13:00 IMMUNOME, INC.: Q1 2024 Earnings Release
14/05/2024 12:00 IMMATICS N.V.: Q1 2024 Earnings Release
13/05/2024 PEPTIDREAM INC.: Q1 2024 Earnings Release
14/05/2024 06:00 NYKODE THERAPEUTICS: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. XBIO Stock
  4. Calendar Xenetic Biosciences, Inc.